This site is intended for healthcare professionals

SGLT2 inhibitors in type 2 diabetes: Recommendations within updated NICE guideline NG28

Posted 14 Feb 2022

Dr Anish Kotecha MRCGP FAcadMEd MBBCh BSc

Dr Anish Kotecha explores the recommendations on sodium–glucose cotransporter 2 (SGLT2) inhibitors within updated guidance on type 2 diabetes management in adults from NICE.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.